CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 329.00
+10.00 (3.13%)
Jun 3, 2026, 3:30 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.33 billion as of June 3, 2026. Its market cap has decreased by -50.61% in one year.
Market Cap
6.33B
Enterprise Value
1.71B
Revenue
3.72B
Ranking
n/a
PE Ratio
70.97
Stock Price
329.00
Market Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.33B, a decrease of -53.03%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 6.33B | -19.95% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.77B |
| Kidswell Bio | 7.74B |
| ADR120S | 7.10B |
| BrightPath Biotherapeutics | 7.03B |
| Kubota Pharmaceutical Holdings | 6.81B |
| StemCell Institute | 6.63B |
| Soiken Holdings | 6.30B |
| TMS Co., Ltd. | 5.91B |